Anson Funds Management LP

Insider Reports History

Entity
Company
Location
16000 Dallas Parkway, Suite 800, Dallas, TX
Signature
/s/ Tony Moore, manager of Anson Management GP LLC, general partner of Anson Funds Management LP
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anson Funds Management LP:

Stock Role Class Num Shares Value Price $ Report Date Ownership
MEI Pharma, Inc. 10%+ Owner Common Stock 1.09M $7.65M $7.00 Oct 20, 2023 Indirect
Trilogy International Partners Inc. 10%+ Owner Common Shares, no par value 8.98M Dec 20, 2023 Indirect
MEI Pharma, Inc. 10%+ Owner Put Option (obligation to buy) 0 Oct 20, 2023 Indirect

Insider Reports Filed by Anson Funds Management LP

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TRLH Trilogy International Partners Inc. Nov 14, 2023 4 -$29.9K 4 Feb 26, 2024 10%+ Owner
MEIP MEI Pharma, Inc. Oct 20, 2023 5 $1.25M 4 Oct 24, 2023 10%+ Owner
MEIP MEI Pharma, Inc. Oct 11, 2023 4 $350K 4 Oct 13, 2023 10%+ Owner
MEIP MEI Pharma, Inc. Sep 22, 2023 2 $328K 4 Sep 25, 2023 10%+ Owner
MEIP MEI Pharma, Inc. Sep 20, 2023 2 $938K 4 Sep 22, 2023 10%+ Owner
MEIP MEI Pharma, Inc. May 19, 2023 0 $0 3 May 30, 2023 10%+ Owner
TRL.H Trilogy International Partners Inc. Jan 1, 2023 0 $0 3 Jan 13, 2023 10%+ Owner